TB-500 Dosage: Loading Phases, Units, and Honest Numbers

Here is something most TB-500 dosage articles will not tell you: there is no human clinical dosing standard for TB-500. None. Every protocol you have seen, the loading phases, the twice-weekly schedules, the milligram ranges, comes from animal research, veterinary practice, and a decade of self-experimenter convention. That does not make the numbers useless, but it changes how a careful researcher should read them. This guide lays out where the common TB-500 protocols actually come from, how to do the vial math precisely, and where the honest uncertainty sits.

TB-500 is sold for research purposes only. What follows describes published research and common research conventions; it is not medical advice or an instruction for human use.

Key Takeaways

• TB-500 is a synthetic version of the active fragment of thymosin beta-4, a naturally occurring repair-associated protein studied mostly in animal models of tissue injury.
• The widely used research convention is a loading phase of roughly 2 to 2.5 mg twice weekly for 4 to 6 weeks, followed by lower maintenance amounts, but this pattern is convention, not clinical trial output.
• Unlike GLP-1 peptides, TB-500 has no published human titration schedule, so reconstitution math and consistency matter more, not less.
• A 5 mg vial with 2.5 ml of bacteriostatic water gives 2 mg per ml, making a 2 mg measurement 100 units on a U-100 syringe; most researchers use less water for smaller syringe volumes.
• Verified purity is the single biggest dosing variable in practice, because an underdosed vial silently rewrites every number in a protocol.

What TB-500 Is, and Why the Dosing Evidence Is Different

Thymosin beta-4 is a 43 amino acid protein present in nearly all human and animal cells, concentrated in wound fluid and platelets, and heavily studied for its role in actin regulation, cell migration, and tissue repair. TB-500 is the synthetic, research-market version built around its active region. The full background, mechanism, and study landscape are covered in our TB-500 and thymosin beta-4 guide.

The evidence base is real but preclinical: rodent and equine studies of cardiac, corneal, muscle, and tendon injury models. Thymosin beta-4 itself has been through early-phase human safety studies in other contexts, but TB-500 as used in the research market has never had a human dose-finding trial. Compare that with semaglutide or tirzepatide, where dosing schedules come straight from trials with thousands of participants. With TB-500, the protocols circulating online are extrapolations: from animal doses scaled by body weight, from veterinary use in racehorses, and from years of community convention that hardened into “standard” numbers through repetition.

The Common Research Protocol, Honestly Labeled

With that caveat stated plainly, here is the convention most research protocols follow, because readers comparing sources deserve to know what the convention actually is:

The loading-then-maintenance shape mirrors how thymosin beta-4 was administered in animal repair studies, where higher early exposure was followed by lower sustained exposure. The twice-weekly frequency is a practical compromise: thymosin beta-4’s measured plasma half-life is short (hours), but its biological effects in tissue models persist far longer, which is the rationale given for spacing administrations days apart rather than dosing daily.

What you will also see in the wild, and should read skeptically: claims of precise per-kilogram formulas, “cycle” rules copied from steroid forums, and amounts well above 5 mg per administration with no sourcing. None of that traces back to published research.

Vial Math: From Milligrams to Syringe Units

TB-500 typically ships as 5 mg or 10 mg of lyophilized powder. The concentration you create at reconstitution defines every later measurement, so write it on the vial immediately. The formula: mg of peptide divided by ml of bacteriostatic water equals mg per ml; on a U-100 insulin syringe, 1 unit is 0.01 ml.

Worked examples for a 5 mg vial:

• 1 ml of water: 5 mg/ml, so 0.05 mg per unit. A 2.5 mg measurement = 50 units. A 2 mg measurement = 40 units.
• 2 ml of water: 2.5 mg/ml, so 0.025 mg per unit. A 2.5 mg measurement = 100 units (a full syringe). A 2 mg measurement = 80 units.

For a 10 mg vial with 2 ml of water, the concentration is 5 mg/ml, identical per-unit math to the first example. Most researchers prefer concentrations that keep a single measurement under about 50 units for comfortable handling. Our peptide dosage calculator runs these numbers for any combination, and peptide storage mistakes covers what degrades a reconstituted vial (heat, light, agitation, and time; refrigerate and use within roughly 3 to 4 weeks).

What Most People Get Wrong

Treating convention as clinical fact. The 2 to 2.5 mg twice-weekly pattern is reasonable convention, but a researcher should document it as such. If a source claims “studies show the optimal TB-500 dose is X,” ask which study. There is not one.

Ignoring the purity variable. TB-500 is one of the most frequently underdosed peptides in independent lab testing of gray-market products. If a vial labeled 5 mg contains 3.5 mg, a “2.5 mg” measurement is actually 1.75 mg. Every dosing debate downstream is noise compared to this. A verifiable third-party certificate of analysis is the only fix.

Daily dosing. Some protocols copy daily schedules from short half-life peptides like BPC-157. The TB-500 convention is deliberately spaced; daily administration just multiplies consumption without a research rationale.

Confusing TB-500 with BPC-157 roles in a stack. They are studied for overlapping but different repair mechanisms, which is why the two are often run together in what the community calls the Wolverine stack. Amounts for each are set independently; see our Wolverine stack guide, the BPC-157 dosage guide, and the BPC-157 vs TB-500 comparison for how researchers structure that pairing.

Administration and Handling Notes

• Research convention is subcutaneous administration, with some protocols using intramuscular near the area of interest; systemic distribution makes the site less critical than with localized compounds. The trade-offs are covered in subcutaneous vs intramuscular administration.
• Lyophilized TB-500 stores refrigerated for extended periods; reconstituted vials belong in the fridge and should be used within weeks, not months.
• In tropical climates, cold-chain handling from supplier to fridge is part of dosing accuracy, because heat-degraded peptide is effectively underdosed peptide.
• Recovery-focused researchers usually plan TB-500 alongside training and rehab variables; our recovery stack overview and healing and injury research guide give that wider context.

What To Check Before You Buy

• A real, verifiable COA. Janoshik or an equivalent independent lab, with a certificate number you can check, dated recently and matching the batch.
• Plausible pricing. TB-500 synthesis is not cheap; deep-discount 10 mg vials are where underdosing hides.
• Honest framing. A supplier claiming TB-500 is a proven human therapeutic is misrepresenting the evidence; that should disqualify them on trust alone.
• Storage and shipping practice. Ask how the product is stored locally. In Bali, that question matters more than anywhere.

FAQ

What is the standard TB-500 dosage in research?

There is no clinically established human dose. The common research convention is 2 to 2.5 mg twice weekly for a 4 to 6 week loading phase, then once weekly or less for maintenance. This pattern derives from animal research and community convention, not human trials.

How many units is 2.5 mg of TB-500?

With a 5 mg vial reconstituted in 1 ml of bacteriostatic water, 2.5 mg is 50 units on a U-100 insulin syringe. With 2 ml of water it is 100 units. The reconstitution volume defines the conversion.

Why is TB-500 dosed twice weekly instead of daily?

Although its plasma half-life is short, the biological effects observed in tissue-repair models persist for days, and the research convention spaces administrations accordingly. Daily dosing has no published rationale for this compound.

Can TB-500 and BPC-157 be used in the same research protocol?

The combination, often called the Wolverine stack, is common in repair-focused research designs because the two peptides are studied for complementary mechanisms. Amounts for each are set independently using their own conventions.

How long does reconstituted TB-500 last?

Refrigerated with bacteriostatic water, roughly 3 to 4 weeks is the standard working window. Unmixed lyophilized powder keeps far longer when cold and protected from light.

Summary

TB-500 dosing is a place where honesty is a competitive advantage: the loading and maintenance convention is real and widely used, but it rests on animal data and accumulated practice, not human trials. Do the reconstitution math explicitly, document the convention as a convention, space administrations as designed, and treat verified purity as the foundation every number stands on.

Peptide+ stocks third-party tested TB-500 and BPC-157 in Bali with verifiable Janoshik certificates and refrigerated handling. Browse the catalog at peptideplus.shop.

All products are sold strictly for research purposes. This article is educational and does not constitute medical advice.

Shop Research Peptides